UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies

Journal of clinical microbiology, 2020-09, Vol.58 (10)

2020

Link zum Volltext

Verfügbarkeit prüfen

Label-free impedimetric immunosensor for point-of-care detection of COVID-19 antibodies

Microsystems & nanoengineering, 2023-01, Vol.9 (1), p.3-3, Article 3

2023

Link zum Volltext

Verfügbarkeit prüfen

Identifying gaps in the treatment of hepatitis C in patients co-infected with HIV in Edmonton, Alberta

Annals of hepatology, 2021-07, Vol.23, p.100283-100283, Article 100283

2021

Link zum Volltext

Verfügbarkeit prüfen

Faradaic Impedimetric Immunosensor for Label-Free Point-of-Care Detection of COVID-19 Antibodies Using Gold-Interdigitated Electrode Array

Biosensors (Basel), 2024-01, Vol.14 (1), p.6

2024

Link zum Volltext

Verfügbarkeit prüfen

Baseline assessment of and linkage to care for newly diagnosed patients with chronic hepatitis B

Canadian liver journal, 2020-08, Vol.3 (3), p.263-275

2020

Link zum Volltext

Verfügbarkeit prüfen

Reply to: “Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany”

Journal of hepatology, 2024-04, Vol.80 (4), p.e176-e177

2024

Link zum Volltext

Verfügbarkeit prüfen

A low-cost initiative to reduce duplicate hepatitis B virus serological testing

Practical laboratory medicine, 2021-03, Vol.24, p.e00205-e00205, Article e00205

2021

Link zum Volltext

Verfügbarkeit prüfen

Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic

Microbiology spectrum, 2021-09, Vol.9 (1), p.e0029121-e0029121

2021

Link zum Volltext

Verfügbarkeit prüfen

A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection

Journal of clinical microbiology, 2021-03, Vol.59 (4)

2021

Link zum Volltext

Verfügbarkeit prüfen

How to determine protective immunity in the post-vaccine era

Human vaccines & immunotherapeutics, 2016-04, Vol.12 (4), p.903-906

2016

Link zum Volltext

Verfügbarkeit prüfen

Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections

Clinical microbiology reviews, 2019-01, Vol.32 (1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Measles Virus-Specific IgM Antibodies

Journal of clinical microbiology, 2021-05, Vol.59 (6)

2021

Link zum Volltext

Verfügbarkeit prüfen

Pseudomonas aeruginosa Minor Pilins Prime Type IVa Pilus Assembly and Promote Surface Display of the PilY1 Adhesin

The Journal of biological chemistry, 2015-01, Vol.290 (1), p.601-611

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation and comparison of risk-based and universal prenatal HCV screening programs in Alberta, Canada

Journal of hepatology, 2023-11, Vol.79 (5), p.1121-1128

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers

Annals of hepatology, 2018-03, Vol.17 (2), p.232-241

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Rubella Virus-Specific IgM Antibodies

Journal of clinical microbiology, 2022-01, Vol.60 (1), p.e0159721-e0159721

2022

Link zum Volltext

Verfügbarkeit prüfen

Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints

Journal of clinical microbiology, 2017-02, Vol.55 (2), p.450-456

2017

Link zum Volltext

Verfügbarkeit prüfen

Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints

Journal of clinical microbiology, 2015-03, Vol.53 (3), p.816-823

2015

Link zum Volltext

Verfügbarkeit prüfen

What’s in a number? The value of titers as routine proof of immunity for medical students

Vaccine, 2023-04, Vol.41 (17), p.2734-2738

2023

Link zum Volltext

Verfügbarkeit prüfen

Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests

Vaccine, 2021-09, Vol.39 (39), p.5563-5570

2021

Link zum Volltext

Verfügbarkeit prüfen

How To Prepare for the Unexpected: a Public Health Laboratory Response

Clinical microbiology reviews, 2021-06, Vol.34 (3)

2021

Link zum Volltext

Verfügbarkeit prüfen

Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage

Journal of clinical microbiology, 2014-11, Vol.52 (11), p.3898-3905

2014

Link zum Volltext

Verfügbarkeit prüfen

The effect of first-wave COVID-19 restrictions on HCV testing in Alberta, Canada: A trend analysis from 2019 to 2022

Canadian liver journal, 2024-05, Vol.7 (2), p.273-285

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the Vitek MS and Bruker Microflex LT MALDI-TOF MS platforms for routine identification of commonly isolated bacteria and yeast in the clinical microbiology laboratory

Diagnostic microbiology and infectious disease, 2015-01, Vol.81 (1), p.27-33

2015

Link zum Volltext

Verfügbarkeit prüfen

Overview of a Provincial Prenatal Communicable Disease Screening Program: 2002-2016

Journal of obstetrics and gynaecology Canada, 2020-03, Vol.42 (3), p.269-276

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(54)
Reviews
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies

Label-free impedimetric immunosensor for point-of-care detection of COVID-19 antibodies

Identifying gaps in the treatment of hepatitis C in patients co-infected with HIV in Edmonton, Alberta

Faradaic Impedimetric Immunosensor for Label-Free Point-of-Care Detection of COVID-19 Antibodies Using Gold-Interdigitated Electrode Array

Baseline assessment of and linkage to care for newly diagnosed patients with chronic hepatitis B

Reply to: “Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany”

A low-cost initiative to reduce duplicate hepatitis B virus serological testing

Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic

A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection

How to determine protective immunity in the post-vaccine era

Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Measles Virus-Specific IgM Antibodies

Pseudomonas aeruginosa Minor Pilins Prime Type IVa Pilus Assembly and Promote Surface Display of the PilY1 Adhesin

Evaluation and comparison of risk-based and universal prenatal HCV screening programs in Alberta, Canada

Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Rubella Virus-Specific IgM Antibodies

Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints

Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints

What’s in a number? The value of titers as routine proof of immunity for medical students

Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests

How To Prepare for the Unexpected: a Public Health Laboratory Response

Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage

The effect of first-wave COVID-19 restrictions on HCV testing in Alberta, Canada: A trend analysis from 2019 to 2022

Comparison of the Vitek MS and Bruker Microflex LT MALDI-TOF MS platforms for routine identification of commonly isolated bacteria and yeast in the clinical microbiology laboratory

Overview of a Provincial Prenatal Communicable Disease Screening Program: 2002-2016

Suchergebnisse filtern